Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α

BACKGROUND: Zinc-α2-glycoprotein 1 (AZGP1) plays important roles in metabolism-related diseases. The underlying molecular mechanisms and therapeutic effects of AZGP1 remain unknown in non-alcoholic fatty liver disease (NAFLD). AIM: To explore the effects and potential mechanism of AZGP1 on NAFLD in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ting, Luo, Xin, Li, Zheng-Hong, Wu, Jun-Cheng, Luo, Sheng-Zheng, Xu, Ming-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767980/
https://www.ncbi.nlm.nih.gov/pubmed/31576092
http://dx.doi.org/10.3748/wjg.v25.i36.5451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767980/
https://www.ncbi.nlm.nih.gov/pubmed/31576092
http://dx.doi.org/10.3748/wjg.v25.i36.5451

Ejemplares similares